ReviewCancer drug resistance (Alhambra, Calif.)2022
Drug resistance and minimal residual disease in multiple myeloma.
Alessandro Gozzetti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ReviewCancer drug resistance (Alhambra, Calif.)2022
Alessandro Gozzetti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.